High quality reagents for innate immunity research, vaccine development and drug discovery

		Natural product extract libraries 800 extracts of traditional herbs and medicines with a unique focus to maximise activity and safety.		Natural compound libraries 200 pure natural compunds chosen to maximise activity and hit-rate in diverse biological screens.
		Recombinant RBD protein Recombinant SARS-CoV-2 Spike protein receptor binding domain (RBD) protein for serological and vaccine research.		Recombinant flagellin protein Flagellin protein lacking the hypervariable D3 domain, for vaccine and innate immunity research, uniquely expressed in mammalian cells.		Flagellin-RBD fusion protein Recombinant fusion protein comprising mammalian expressed flagellin with the SARS-CoV2 RBD protein replacing the D3 domain for vaccine research.
		Recombinant flagellin protein Full-length flagellin protein including the hypervariable D3 domain, for vaccine and innate immunity research, uniquely expressed in mammalian cells.		Flagellin-RBD fusion protein Recombinant fusion protein comprising mammalian expressed full-length flagellin with the SARS-CoV2 RBD protein at the C-terminus, for vaccine research.
		Human LPS-binding protein Recombinant human LPS-binding protein expressed in mammalian cells for extremely low PAMP content.		Human CD14 protein Recombinant human soluble CD14 protein expressed in mammalian cells for extremely low PAMP content.

 

 

Caithness Biotechnologies Ltd., 72 Boston Road, Leicester, UK, LE4 1HB. Telephone: +44 (0) 116 326 3802 | email: contact@caithnessbiotechnologies.com